Franklin Resources Inc Meridian Bioscience Inc Transaction History

Franklin Resources Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$31.15 - $33.39 $3,364 - $3,606	-108 Reduced 0.74%	14,553 $483,000
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $4,109 - $4,462	133 Added 0.92%	14,661 $462,000
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $90,155 - $120,295	-3,796 Reduced 20.72%	14,528 $441,000
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $9,705 - $13,092	486 Added 2.72%	18,324 $475,000
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $10,458 - $12,944	-599 Reduced 3.25%	17,838 $364,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $319,881 - $414,832	18,437 New	18,437 $355,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.